Canadian drug maker raises C$45m Series C round

Japanese pharmaceutical company Mitsubishi Tanabe Pharma has led a funding round for Cytochroma that included contributions from Canadian pension La Caisse de dépôt et placement du Québec, Canadian government-backed BDC Capital and four retail venture capital funds.